Insider Selling: Beigene, Ltd. (NASDAQ:ONC) Insider Sells 5,000 Shares of Stock

Beigene, Ltd. (NASDAQ:ONCGet Free Report) insider Lai Wang sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $257.23, for a total transaction of $1,286,150.00. Following the sale, the insider now directly owns 920,920 shares of the company’s stock, valued at approximately $236,888,251.60. This trade represents a 0.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Beigene Price Performance

Shares of NASDAQ ONC opened at $259.00 on Thursday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.72 and a current ratio of 1.93. The firm has a market cap of $25.35 billion, a P/E ratio of -31.43, a P/E/G ratio of 7.73 and a beta of 0.63. Beigene, Ltd. has a 12-month low of $126.97 and a 12-month high of $268.45.

About Beigene

(Get Free Report)

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.

Further Reading

Receive News & Ratings for Beigene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beigene and related companies with MarketBeat.com's FREE daily email newsletter.